Understanding the mechanism of bacterial biofilms resistance to antimicrobial agents

Open Microbiology Journal

Volumn 11, Issue , 2017, Pages 53-62

  Singh, Shriti ^a   Singh, Santosh Kumar ^b   Chowdhury, Indrajit ^b   Singh, Rajesh ^b  

^a BANARAS HINDU UNIVERSITY   (India)

^b MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

Biofilm; Efflux pump; Heterogeneity; Quorum sensing; Resistance

Indexed keywords

ANTIINFECTIVE AGENT; BACTERICIDE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; BACTERIUM COLONY; BACTERIUM TRANSFORMATION; BIOFILM; CELL HETEROGENEITY; CLINICAL OUTCOME; EFFUSION; EVOLUTIONARY ADAPTATION; GENE IDENTIFICATION; GLYCOCALYX; GROWTH RATE; METABOLISM; METABOLITE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; QUORUM SENSING; REVIEW; STRESS;

EID: 85020412868     PISSN: None     EISSN: 18742858     Source Type: Journal    
DOI: 10.2174/1874285801711010053     Document Type: Review

References (86)

1. Donlan RM. Biofilms: Microbial life on surfaces. Emerg Infect Dis 2002; 8(9): 881-90.
2. Anderl JN, Franklin MJ, Stewart PS. Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob Agents Chemother 2000; 44(7): 1818-24.
3. Bryers JD. Bacterial biofilms. Curr Opin Biotechnol 1993; 4(2): 197-204.
4. Windler M, Leinweber K, Bartulos CR, Philipp B, Kroth PG. Biofilm and capsule formation of the diatom Achnanthidium minutissimum are affected by a bacterium. J Phycol 2015; 51(2): 343-55.
5. Flemming HC, Wingender J. Relevance of microbial extracellular polymeric substances (EPSs) Part I: Structural and ecological aspects. Water Sci Technol 2001; 43(6): 1-8.
6. Costerton JW. Structure and plasticity at various organization levels in the bacterial cell. Can J Microbiol 1988; 34(4): 513-21.
7. Peña J, Bargar JR, Sposito G. Role of bacterial biomass in the sorption of Ni by biomass-birnessite assemblages. Environ Sci Technol 2011; 45(17): 7338-44.
8. Sutherland IW. The biofilm matrixan immobilized but dynamic microbial environment. Trends Microbiol 2001; 9(5): 222-7.
9. Anwar H, Dasgupta MK, Costerton JW. Testing the susceptibility of bacteria in biofilms to antibacterial agents. Antimicrob Agents Chemother 1990; 34(11): 2043-6.
10. Sugano M, Morisaki H, Negishi Y, et al. Potential effect of cationic liposomes on interactions with oral bacterial cells and biofilms. J Liposome Res 2016; 26(2): 156-62.
11. Hoyle BD, Jass J, Costerton JW. The biofilm glycocalyx as a resistance factor. J Antimicrob Chemother 1990; 26(1): 1-5.
12. Arciola CR, Campoccia D, Speziale P, Montanaro L, Costerton JW. Biofilm formation in Staphylococcus implant infections. A review of molecular mechanisms and implications for biofilm-resistant materials. Biomaterials 2012; 33(26): 5967-82.
13. Brown SM, Howell ML, Vasil ML, Anderson AJ, Hassett DJ. Cloning and characterization of the katB gene of Pseudomonas aeruginosa encoding a hydrogen peroxide-inducible catalase: purification of KatB, cellular localization, and demonstration that it is essential for optimal resistance to hydrogen peroxide. J Bacteriol 1995; 177(22): 6536-44.
14. Kümmerle N, Feucht HH, Kaulfers PM. Plasmid-mediated formaldehyde resistance in Escherichia coli: characterization of resistance gene. Antimicrob Agents Chemother 1996; 40(10): 2276-9.
15. Ryall B, Eydallin G, Ferenci T. Culture history and population heterogeneity as determinants of bacterial adaptation: the adaptomics of a single environmental transition. Microbiol Mol Biol Rev 2012; 76(3): 597-625.
16. Stewart PS. Diffusion in biofilms. J Bacteriol 2003; 185(5): 1485-91.
17. Kolek J, Branska B, Drahokoupil M, Patakova P, Melzoch K. Evaluation of viability, metabolic activity and spore quantity in clostridial cultures during ABE fermentation. FEMS Microbiol Lett 2016; 363(6): fnw031.
18. Wentland EJ, Stewart PS, Huang CT, McFeters GA. Spatial variations in growth rate within Klebsiella pneumoniae colonies and biofilm. Biotechnol Prog 1996; 12(3): 316-21.
19. Poulsen LK, Ballard G, Stahl DA. Use of rRNA fluorescence in situ hybridization for measuring the activity of single cells in young and established biofilms. Appl Environ Microbiol 1993; 59(5): 1354-60.
20. Mitchison JM. Enzyme synthesis in synchronous cultures. Science 1969; 165(3894): 657-63.
21. Sternberg C, Christensen BB, Johansen T, et al. Distribution of bacterial growth activity in flow-chamber biofilms. Appl Environ Microbiol 1999; 65(9): 4108-17.
22. Gilbert P, Maira-Litran T, McBain AJ, Rickard AH, Whyte FW. The physiology and collective recalcitrance of microbial biofilm communities. Adv Microb Physiol 2002; 46: 202-56.
23. Betzner AS, Ferreira LC, Höltje JV, Keck W. Control of the activity of the soluble lytic transglycosylase by the stringent response in Escherichia coli. FEMS Microbiol Lett 1990; 55(1-2): 161-4.
24. Shigeta M, Komatsuzawa H, Sugai M, Suginaka H, Usui T. Effect of the growth rate of Pseudomonas aeruginosa biofilms on the susceptibility to antimicrobial agents. Chemotherapy 1997; 43(2): 137-41.
25. Walters MC III, Roe F, Bugnicourt A, Franklin MJ, Stewart PS. Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob Agents Chemother 2003; 47(1): 317-23.
26. Tresse O, Jouenne T, Junter GA. The role of oxygen limitation in the resistance of agar-entrapped, sessile-like Escherichia coli to aminoglycoside and beta-lactam antibiotics. J Antimicrob Chemother 1995; 36(3): 521-6.
27. Shan Y, Brown Gandt A, Rowe SE, Deisinger JP, Conlon BP, Lewis K. ATP-dependent persister formation in Escherichia coli. MBio 2017; 8(1): e02267-16.
28. Lewis K. Persister cells and the riddle of biofilm survival. Biochemistry (Mosc) 2005; 70(2): 267-74.
29. Brooun A, Liu S, Lewis K. A dose-response study of antibiotic resistance in Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother 2000; 44(3): 640-6.
30. del Pozo JL, Patel R. The challenge of treating biofilm-associated bacterial infections. Clin Pharmacol Ther 2007; 82(2): 204-9.
31. Lewis K. Programmed death in bacteria. Microbiol Mol Biol Rev 2000; 64(3): 503-14.
32. Lewis K. Persister cells, dormancy and infectious disease. Nat Rev Microbiol 2007; 5(1): 48-56.
33. Keren I, Shah D, Spoering A, Kaldalu N, Lewis K. Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J Bacteriol 2004; 186(24): 8172-80.
34. Falla TJ, Chopra I. Joint tolerance to beta-lactam and fluoroquinolone antibiotics in Escherichia coli results from overexpression of hipA. Antimicrob Agents Chemother 1998; 42(12): 3282-4.
35. Keren I, Kaldalu N, Spoering A, Wang Y, Lewis K. Persister cells and tolerance to antimicrobials. FEMS Microbiol Lett 2004; 230(1): 13-8.
36. Shockman GD, Daneo-Moore L, Kariyama R, Massidda O. Bacterial walls, peptidoglycan hydrolases, autolysins, and autolysis. Microb Drug Resist 1996; 2(1): 95-8.
37. Gilbert P, Allison DG, Evans DJ, Handley PS, Brown MR. Growth rate control of adherent bacterial populations. Appl Environ Microbiol 1989; 55(5): 1308-11.
38. Brown MR, Allison DG, Gilbert P. Resistance of bacterial biofilms to antibiotics: A growth-rate related effect? J Antimicrob Chemother 1988; 22(6): 777-80.
39. Gefen O, Chekol B, Strahilevitz J, Balaban NQ. TDtest: easy detection of bacterial tolerance and persistence in clinical isolates by a modified disk-diffusion assay. Sci Rep 2017; 7: 41284.
40. Joo H S, Otto M. Mechanisms of resistance to antimicrobial peptides in staphylococci. Biochim Biophys Acta 2015; 1848(11 Pt B): 3055-61.
41. Vlková B, Szemes T, Minárik G, et al. Food-borne enterococci and their resistance to oxidative stress. J Microbiol 2011; 49(4): 657-62.
42. Maira-Litrán T, Allison DG, Gilbert P. An evaluation of the potential of the multiple antibiotic resistance operon (mar) and the multidrug efflux pump acrAB to moderate resistance towards ciprofloxacin in Escherichia coli biofilms. J Antimicrob Chemother 2000; 45(6): 789-95.
43. Farr SB, Kogoma T. Oxidative stress responses in Escherichia coli and Salmonella typhimurium. Microbiol Rev 1991; 55(4): 561-85.
44. Williams P, Winzer K, Chan WC, Cámara M. Look whos talking: communication and quorum sensing in the bacterial world. Philos Trans R Soc Lond B Biol Sci 2007; 362(1483): 1119-34.
45. Sgaragli G, Frosini M. Human Tuberculosis II. M. tuberculosis mechanisms of genetic and phenotypic resistance to anti-tuberculosis drugs. Curr Med Chem 2016; 23(12): 1186-216.
46. Suntharalingam P, Cvitkovitch DG. Quorum sensing in streptococcal biofilm formation. Trends Microbiol 2005; 13(1): 3-6.
47. Talagrand-Reboul E, Jumas-Bilak E, Lamy B. The social life of aeromonas through biofilm and quorum sensing systems. Front Microbiol 2017; 8: 37.
48. Platt TG, Fuqua C. Whats in a name? The semantics of quorum sensing. Trends Microbiol 2010; 18(9): 383-7.
49. Newton JA, Fray RG. Integration of environmental and host-derived signals with quorum sensing during plant-microbe interactions. Cell Microbiol 2004; 6(3): 213-24.
50. Parsek MR, Val DL, Hanzelka BL, Cronan JE Jr, Greenberg EP. Acyl homoserine-lactone quorum-sensing signal generation. Proc Natl Acad Sci USA 1999; 96(8): 4360-5.
51. Watnick P, Kolter R. Biofilm, city of microbes. J Bacteriol 2000; 182(10): 2675-9.
52. Abee T, Kovács AT, Kuipers OP, van der Veen S. Biofilm formation and dispersal in Gram-positive bacteria. Curr Opin Biotechnol 2011; 22(2): 172-9.
53. Hassett DJ, Ma JF, Elkins JG, et al. Quorum sensing in Pseudomonas aeruginosa controls expression of catalase and superoxide dismutase genes and mediates biofilm susceptibility to hydrogen peroxide. Mol Microbiol 1999; 34(5): 1082-93.
54. Shih PC, Huang CT. Effects of quorum-sensing deficiency on Pseudomonas aeruginosa biofilm formation and antibiotic resistance. J Antimicrob Chemother 2002; 49(2): 309-14.
55. Weinberg ED. Iron availability and infection. Biochim Biophys Acta 2009; 1790(7): 600-5.
56. Schertzer JW, Boulette ML, Whiteley M. More than a signal: non-signaling properties of quorum sensing molecules. Trends Microbiol 2009; 17(5): 189-95.
57. Lee S, Hinz A, Bauerle E, et al. Targeting a bacterial stress response to enhance antibiotic action. Proc Natl Acad Sci USA 2009; 106(34): 14570-5.
58. Lee IS, Lin J, Hall HK, Bearson B, Foster JW. The stationary-phase sigma factor sigma S (RpoS) is required for a sustained acid tolerance response in virulent Salmonella typhimurium. Mol Microbiol 1995; 17(1): 155-67.
59. Xu KD, Franklin MJ, Park CH, McFeters GA, Stewart PS. Gene expression and protein levels of the stationary phase sigma factor, RpoS, in continuously-fed Pseudomonas aeruginosa biofilms. FEMS Microbiol Lett 2001; 199(1): 67-71.
60. Brown MR, Barker J. Unexplored reservoirs of pathogenic bacteria: protozoa and biofilms. Trends Microbiol 1999; 7(1): 46-50.
61. Drenkard E. Antimicrobial resistance of Pseudomonas aeruginosa biofilms. Microbes Infect 2003; 5(13): 1213-9.
62. Singh PR, Bajaj H, Benz R, Winterhalter M, Mahendran KR. Transport across the outer membrane porin of mycolic acid containing actinomycetales: Nocardia farcinica. Biochim Biophys Acta 2015; 1848(2): 654-61.
63. Brözel VS, Cloete TE. Resistance of Pseudomonas aeruginosa to isothiazolone. J Appl Bacteriol 1994; 76(6): 576-82.
64. Hogan D, Kolter R. Why are bacteria refractory to antimicrobials? Curr Opin Microbiol 2002; 5(5): 472-7.
65. Liaw SJ, Lee YL, Hsueh PR. Multidrug resistance in clinical isolates of Stenotrophomonas maltophilia: roles of integrons, efflux pumps, phosphoglucomutase (SpgM), and melanin and biofilm formation. Int J Antimicrob Agents 2010; 35(2): 126-30.
66. Davin-Regli A, Bolla JM, James CE, et al. Membrane permeability and regulation of drug influx and efflux in enterobacterial pathogens. Curr Drug Targets 2008; 9(9): 750-9.
67. Bolla JM, Alibert-Franco S, Handzlik J, et al. Strategies for bypassing the membrane barrier in multidrug resistant Gram-negative bacteria. FEBS Lett 2011; 585(11): 1682-90.
68. Richmond GE, Evans LP, Anderson MJ, et al. The Acinetobacter baumannii two-component system AdeRS regulates genes required for multidrug efflux, biofilm formation, and virulence in a strain-specific manner. MBio 2016; 7(2): e00430-16.
69. Schindler BD, Kaatz GW. Multidrug efflux pumps of Gram-positive bacteria. Drug Resist Updat 2016; 27: 1-13.
70. Li XZ, Nikaido H. Efflux-mediated drug resistance in bacteria. Drugs 2004; 64(2): 159-204.
71. Pagès JM, James CE, Winterhalter M. The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria. Nat Rev Microbiol 2008; 6(12): 893-903.
72. Markham PN, Neyfakh AA. Efflux-mediated drug resistance in Gram-positive bacteria. Curr Opin Microbiol 2001; 4(5): 509-14.
73. Kumar A, Schweizer HP. Bacterial resistance to antibiotics: active efflux and reduced uptake. Adv Drug Deliv Rev 2005; 57(10): 1486-513.
74. Poole K. Efflux-mediated antimicrobial resistance. J Antimicrob Chemother 2005; 56(1): 20-51.
75. Levy SB. Active efflux mechanisms for antimicrobial resistance. Antimicrob Agents Chemother 1992; 36(4): 695-703.
76. Ma D, Cook DN, Alberti M, Pon NG, Nikaido H, Hearst JE. Molecular cloning and characterization of acrA and acrE genes of Escherichia coli. J Bacteriol 1993; 175(19): 6299-313.
77. Whiteley M, Bangera MG, Bumgarner RE, et al. Gene expression in Pseudomonas aeruginosa biofilms. Nature 2001; 413(6858): 860-4.
78. Maira-Litrán T, Allison DG, Gilbert P. Expression of the multiple antibiotic resistance operon (mar) during growth of Escherichia coli as a biofilm. J Appl Microbiol 2000; 88(2): 243-7.
79. Alekshun MN, Levy SB. Regulation of chromosomally mediated multiple antibiotic resistance: the mar regulon. Antimicrob Agents Chemother 1997; 41(10): 2067-75.
80. Cohen SP, Levy SB, Foulds J, Rosner JL. Salicylate induction of antibiotic resistance in Escherichia coli: activation of the mar operon and a mar-independent pathway. J Bacteriol 1993; 175(24): 7856-62.
81. Seoane AS, Levy SB. Characterization of MarR, the repressor of the multiple antibiotic resistance (mar) operon in Escherichia coli. J Bacteriol 1995; 177(12): 3414-9.
82. Ma D, Cook DN, Alberti M, Pon NG, Nikaido H, Hearst JE. Genes acrA and acrB encode a stress-induced efflux system of Escherichia coli. Mol Microbiol 1995; 16(1): 45-55.
83. Ma D, Alberti M, Lynch C, Nikaido H, Hearst JE. The local repressor AcrR plays a modulating role in the regulation of acrAB genes of Escherichia coli by global stress signals. Mol Microbiol 1996; 19(1): 101-12.
84. De Kievit TR, Parkins MD, Gillis RJ, et al. Multidrug efflux pumps: Expression patterns and contribution to antibiotic resistance in Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother 2001; 45(6): 1761-70.
85. Martínez JL. Effect of antibiotics on bacterial populations: A multi-hierachical selection process. F1000 Res 2017; 6: 51.
86. Lebeaux D, Ghigo JM, Beloin C. Biofilm-related infections: Bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics. Microbiol Mol Biol Rev 2014; 78(3): 510-43.